DVA vs STOK · P/E 14, rev $12.82B vs rev $36.6M
DaVita HealthCare Partners Inc (DVA) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. STOK currently screens at market cap $1.88B.
Not investment advice. Open the DVA and STOK stock pages for the full models.
Not investment advice.